» Articles » PMID: 2037368

Immunochemical Characterization of Two Surface Polysaccharides of Bacteroides Fragilis

Overview
Journal Infect Immun
Date 1991 Jun 1
PMID 2037368
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Immunochemical analysis of the capsular polysaccharide from Bacteroides fragilis NCTC 9343 revealed a novel structure composed of two distinct polysaccharides. Immunoelectrophoresis of an extract of purified surface polysaccharide from fermenter-grown organisms showed a complex precipitin profile with varying anodal mobility. DEAE-Sephacel anion-exchange chromatography of the polysaccharide extract failed to separate the majority of this aggregate. Disaggregation of this complex was accomplished by very mild acid treatment; purification was achieved by DEAE-Sephacel anion-exchange chromatography. Polysaccharide A had a neutral charge at pH 7.3, a net negative charge at pH 8.6, and an average Mr = 110,000; chemical analysis showed it to contain galactose, galactosamine, and an unidentified amino sugar. Polysaccharide B eluted from the anion-exchange column with increased salt concentration; it had a net negative charge and an average Mr = 200,000, and contained fucose, galactose, quinovosamine, galacturonic acid, and glucosamine. Neither of these polysaccharides contained detectable 3-deoxy-D-manno-octolusonic acid, and both were recognized as distinct antigens on the basis of their reactivity with monoclonal antibodies CE3 and F10, which reacted with the complex before acid treatment. These data indicate that the capsule of B. fragilis NCTC 9343 comprises two discrete, surface-exposed polysaccharides with differing physiochemical properties that are distinct from the lipopolysaccharide of this organism. The finding of two surface polysaccharides has not been described for other bacteria pathogenic to humans.

Citing Articles

Bacteroides expand the functional versatility of a conserved transcription factor and transcribed DNA to program capsule diversity.

Saba J, Flores K, Marshall B, Engstrom M, Peng Y, Garje A Nat Commun. 2024; 15(1):10862.

PMID: 39738018 PMC: 11685472. DOI: 10.1038/s41467-024-55215-9.


An exopolysaccharide pathway from a freshwater isolate.

Goetsch A, Ufearo D, Keiser G, Heiss C, Azadi P, Hershey D J Bacteriol. 2024; 206(8):e0016924.

PMID: 39007563 PMC: 11340318. DOI: 10.1128/jb.00169-24.


Phosphorothioate DNA modification by BREX Type 4 systems in the human gut microbiome.

Yuan Y, Demott M, Byrne S, Flores K, Poyet M, Groussin M bioRxiv. 2024; .

PMID: 38895356 PMC: 11185695. DOI: 10.1101/2024.06.03.597175.


Distant relatives of a eukaryotic cell-specific toxin family evolved a complement-like mechanism to kill bacteria.

Abrahamsen H, Sanford T, Collamore C, Johnstone B, Coyne M, Garcia-Bayona L Nat Commun. 2024; 15(1):5028.

PMID: 38866748 PMC: 11169675. DOI: 10.1038/s41467-024-49103-5.


A novel exopolysaccharide pathway from a freshwater isolate.

Goetsch A, Ufearo D, Keiser G, Heiss C, Azadi P, Hershey D bioRxiv. 2023; .

PMID: 37961232 PMC: 10635127. DOI: 10.1101/2023.11.03.565537.


References
1.
OUCHTERLONY O . Diffusion-in-gel methods for immunological analysis. Prog Allergy. 1958; 5:1-78. View

2.
Omar A, Weckesser J, Mayer H . Different polysaccharides in the external layers (capsule and slime) of the cell envelope of Rhodopseudomonas capsulata Sp11. Arch Microbiol. 1983; 136(4):291-6. DOI: 10.1007/BF00425219. View

3.
Makela P, Mayer H . Enterobacterial common antigen. Bacteriol Rev. 1976; 40(3):591-632. PMC: 413973. DOI: 10.1128/br.40.3.591-632.1976. View

4.
Polk B, Kasper D . Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med. 1977; 86(5):569-71. DOI: 10.7326/0003-4819-86-5-569. View

5.
Onderdonk A, Kasper D, Cisneros R, Bartlett J . The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis. 1977; 136(1):82-9. DOI: 10.1093/infdis/136.1.82. View